Patents by Inventor Raxit J. Jariwalla

Raxit J. Jariwalla has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040242679
    Abstract: The effect of cancer chemotherapeutic agents is potentiated by combination with) mineral ascorbates, Vitamin C metabolites and/or a Vitamin C-derived furanone, illustratively a 4-hydroxy-5-methyl-3(2H)-furanone.
    Type: Application
    Filed: May 22, 2002
    Publication date: December 2, 2004
    Inventor: Raxit J Jariwalla
  • Publication number: 20040092549
    Abstract: A selective chemotherapy method includes the step of contacting tumor cells with a mineral ascorbate/vitamin C metabolite composition. A chemotherapeutic composition comprises the mineral ascorbate/vitamin C metabolite composition in a pharmacologically acceptable intravenous carrier.
    Type: Application
    Filed: April 30, 2001
    Publication date: May 13, 2004
    Inventor: Raxit J Jariwalla
  • Patent number: 6468980
    Abstract: The effect of cancer chemotherapeutic agents is potentiated by combination with mineral ascorbates, Vitamin C metabolites and/or Vitamin C-derived furanones.
    Type: Grant
    Filed: September 1, 2000
    Date of Patent: October 22, 2002
    Assignee: Oxycal Laboratories, Inc.
    Inventor: Raxit J. Jariwalla